Quality control of small-volume sterile products. 1977

C A Rupp, and C A Kikugawa, and S E Kotabe, and S L Barriere, and W D Bowman

A method for bacterial surveillance of small-volume sterile products in hospitals was developed and tested. The criteria for the method of quality control were to: (1) assure detection of contamination associated with touch, which could occur during the filling process; (2) be economically feasible; (3) be simple and easy to implement; and (4) be versatile in adapting to small-volume sterile packages with and without needles. Ten percent of each lot of prepackaged unit dose syringes is tested by filtration through a sterile micropore filter. The filter unit is incubated after fluid thioglycollate medium has been added. If turbidity or color change is found, further testing with blood agar and gram staining is performed to identify the organism. The effectiveness of the method was tested by adding E. coli to one lot within each of several lots tested of six products. The inoculated samples were stored under refrigeration for three days before testing. With one exception, the E. coli was detected in the samples. Growth did not occur in any of the noninoculated units. The apparent false negative result was believed to be caused by the bacteriostatic agent killing the organism during the three-day storage period.

UI MeSH Term Description Entries
D011786 Quality Control A system for verifying and maintaining a desired level of quality in a product or process by careful planning, use of proper equipment, continued inspection, and corrective action as required. (Random House Unabridged Dictionary, 2d ed) Control, Quality,Controls, Quality,Quality Controls
D004340 Drug Contamination The presence of organisms, or any foreign material that makes a drug preparation impure. Drug Adulteration,Drug Contamination, Chemical,Drug Contamination, Microbial,Drug Contamination, Physical,Drug Impurity,Adulteration, Drug,Chemical Drug Contamination,Chemical Drug Contaminations,Contamination, Chemical Drug,Contamination, Drug,Contamination, Microbial Drug,Contamination, Physical Drug,Contaminations, Chemical Drug,Contaminations, Microbial Drug,Contaminations, Physical Drug,Drug Adulterations,Drug Contaminations,Drug Contaminations, Chemical,Drug Contaminations, Microbial,Drug Contaminations, Physical,Drug Impurities,Impurity, Drug,Microbial Drug Contamination,Microbial Drug Contaminations,Physical Drug Contamination,Physical Drug Contaminations
D004349 Drug Packaging Containers, packaging, and packaging materials for drugs and BIOLOGICAL PRODUCTS. These include those in ampule, capsule, tablet, solution or other forms. Packaging includes immediate-containers, secondary-containers, and cartons. In the United States, such packaging is controlled under the Federal Food, Drug, and Cosmetic Act which also stipulates requirements for tamper-resistance and child-resistance. Similar laws govern use elsewhere. (From Code of Federal Regulations, 21 CFR 1 Section 210, 1993) DRUG LABELING is also available. Drug Containers and Closures,Packaging, Drug,Drug Containers,Container, Drug,Containers, Drug,Drug Container,Drug Packagings,Packagings, Drug
D004364 Pharmaceutical Preparations Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form. Drug,Drugs,Pharmaceutical,Pharmaceutical Preparation,Pharmaceutical Product,Pharmaceutic Preparations,Pharmaceutical Products,Pharmaceuticals,Preparations, Pharmaceutical,Preparation, Pharmaceutical,Preparations, Pharmaceutic,Product, Pharmaceutical,Products, Pharmaceutical
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D013242 Sterilization The destroying of all forms of life, especially microorganisms, by heat, chemical, or other means.
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

C A Rupp, and C A Kikugawa, and S E Kotabe, and S L Barriere, and W D Bowman
September 1970, Hospitals,
C A Rupp, and C A Kikugawa, and S E Kotabe, and S L Barriere, and W D Bowman
January 2001, International journal of pharmaceutical compounding,
C A Rupp, and C A Kikugawa, and S E Kotabe, and S L Barriere, and W D Bowman
August 1969, Annals of allergy,
C A Rupp, and C A Kikugawa, and S E Kotabe, and S L Barriere, and W D Bowman
January 1968, Bulletin of the Parenteral Drug Association,
C A Rupp, and C A Kikugawa, and S E Kotabe, and S L Barriere, and W D Bowman
July 2015, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society,
C A Rupp, and C A Kikugawa, and S E Kotabe, and S L Barriere, and W D Bowman
September 1979, Annals of allergy,
C A Rupp, and C A Kikugawa, and S E Kotabe, and S L Barriere, and W D Bowman
January 2018, International journal of pharmaceutical compounding,
C A Rupp, and C A Kikugawa, and S E Kotabe, and S L Barriere, and W D Bowman
November 1991, American journal of hospital pharmacy,
C A Rupp, and C A Kikugawa, and S E Kotabe, and S L Barriere, and W D Bowman
July 1971, Pharmaceutica acta Helvetiae,
C A Rupp, and C A Kikugawa, and S E Kotabe, and S L Barriere, and W D Bowman
May 1994, American journal of hospital pharmacy,
Copied contents to your clipboard!